Journal
Molecular Genetics and Metabolism
Publication Date
12-1-2025
Volume
146
Issue
4
First Page
109284
Document Type
Open Access Publication
DOI
10.1016/j.ymgme.2025.109284
Rights and Permissions
Muenzer J, Botha J, Amartino H, Giugliani R, Harmatz P, Kampmann C, Link B, Lin SP, Molter D, Raiman J, Scarpa M, Tylki-Szymańska A, Jain S, Whiteman DAH, Burton BK. Clinical characteristics and real-world outcomes in patients with mucopolysaccharidosis II over 18 years: final report of the Hunter Outcome Survey. Mol Genet Metab. 2025 Dec;146(4):109284. doi: 10.1016/j.ymgme.2025.109284. © 2025 Takeda Development Centre Americas Inc. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Muenzer, Joseph; Botha, Jaco; Amartino, Hernan; Giugliani, Roberto; Harmatz, Paul; Kampmann, Christoph; Link, Bianca; Lin, Shuan-Pei; Molter, David; Raiman, Julian; Scarpa, Maurizio; Tylki-Szymańska, Anna; Jain, Siddharth; Whiteman, David A H; and Burton, Barbara K, "Clinical characteristics and real-world outcomes in patients with mucopolysaccharidosis II over 18 years: Final report of the Hunter Outcome Survey." Molecular Genetics and Metabolism. 146, 4. 109284 (2025).
https://digitalcommons.wustl.edu/oa_4/6354
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
